# Not All Ascending Weakness and Numbness Is Guillain-Barré Syndrome: A Report of Two Cases of Copper Deficiency Myelopathy

**Authors:** Natalie L Albright, Danielle Pitter, Karima Benameur

PMC · DOI: 10.7759/cureus.100286 · Cureus · 2025-12-28

## TL;DR

Two cases show copper deficiency can mimic Guillain-Barré Syndrome, emphasizing the need to consider nutritional and surgical history in diagnosing neurological symptoms.

## Contribution

Highlights copper deficiency myelopathy as a differential diagnosis for GBS-like symptoms through clinical case reports.

## Key findings

- Copper deficiency can present with ascending sensory loss and gait instability similar to Guillain-Barré Syndrome.
- Nutritional and surgical history are crucial for diagnosing copper deficiency in patients with neurological symptoms.
- Chronic zinc exposure and malabsorption risk factors should raise suspicion for copper deficiency in such cases.

## Abstract

Copper deficiency can lead to progressive neurological dysfunction, but its symptoms may overlap with other myeloneuropathies, making diagnosis challenging. Clinical features are often nonspecific presentations that may result in initial consideration of alternative neurologic conditions. We present two cases in which copper deficiency was identified after an evolving clinical picture. The first is a 70-year-old woman with a history of esophageal and breast cancer, complicated by esophagectomy and jejunostomy tube feeding, who developed six months of progressive ascending sensory loss and gait instability. The second is an 85-year-old woman with chronic zinc supplementation and denture adhesive use, presenting with two weeks of ascending paresthesias and imbalance. These cases highlight the importance of considering nutritional and surgical history in the evaluation of progressive myeloneuropathy, as well as key physical examination, laboratory, and imaging findings. Clinicians should maintain a high index of suspicion for copper deficiency in patients presenting with Guillain-Barré syndrome (GBS)-like symptoms, particularly those with risk factors for malabsorption or chronic zinc exposure.

## Linked entities

- **Chemicals:** zinc (PubChem CID 23994)
- **Diseases:** Guillain-Barré syndrome (MONDO:0016218), esophageal cancer (MONDO:0007576), breast cancer (MONDO:0004989)

## Full-text entities

- **Diseases:** GBS (MESH:D020275), Copper Deficiency Myelopathy (MESH:C535468), malabsorption (MESH:D008286), Numbness (MESH:D006987), neurological dysfunction (MESH:D009461), gait instability (MESH:D043171), esophageal and breast cancer (MESH:D001943), paresthesias (MESH:D010292), sensory loss (MESH:C580162)
- **Chemicals:** zinc (MESH:D015032)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12848847/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12848847/full.md

## References

16 references — full list in the complete paper: https://tomesphere.com/paper/PMC12848847/full.md

---
Source: https://tomesphere.com/paper/PMC12848847